Novare Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$250K Sell
5,405
-845
-14% -$39.1K 0.02% 180
2025
Q1
$381K Hold
6,250
0.03% 146
2024
Q4
$354K Buy
6,250
+1,325
+27% +$74.9K 0.03% 151
2024
Q3
$255K Buy
4,925
+100
+2% +$5.17K 0.02% 170
2024
Q2
$200K Sell
4,825
-1,005
-17% -$41.7K 0.02% 184
2024
Q1
$316K Buy
5,830
+1,850
+46% +$100K 0.03% 146
2023
Q4
$204K Sell
3,980
-500
-11% -$25.7K 0.02% 166
2023
Q3
$260K Sell
4,480
-188
-4% -$10.9K 0.03% 148
2023
Q2
$299K Buy
4,668
+50
+1% +$3.2K 0.03% 150
2023
Q1
$320K Sell
4,618
-1,480
-24% -$103K 0.04% 143
2022
Q4
$439K Sell
6,098
-5,252
-46% -$378K 0.05% 130
2022
Q3
$807K Sell
11,350
-420
-4% -$29.9K 0.1% 102
2022
Q2
$906K Sell
11,770
-101,710
-90% -$7.83M 0.11% 98
2022
Q1
$8.29M Sell
113,480
-31
-0% -$2.26K 0.88% 46
2021
Q4
$7.08M Sell
113,511
-1,540
-1% -$96K 0.72% 64
2021
Q3
$6.81M Buy
115,051
+1,061
+0.9% +$62.8K 0.76% 66
2021
Q2
$7.62M Buy
113,990
+3,471
+3% +$232K 0.85% 57
2021
Q1
$6.98M Buy
110,519
+1,627
+1% +$103K 0.84% 56
2020
Q4
$6.76M Sell
108,892
-1,170
-1% -$72.6K 0.88% 53
2020
Q3
$6.64M Sell
110,062
-986
-0.9% -$59.4K 0.93% 43
2020
Q2
$6.53M Sell
111,048
-295
-0.3% -$17.3K 0.98% 40
2020
Q1
$6.21M Buy
111,343
+9,465
+9% +$528K 1.09% 33
2019
Q4
$6.54M Buy
101,878
+4,995
+5% +$321K 0.91% 45
2019
Q3
$4.91M Buy
96,883
+21,754
+29% +$1.1M 0.73% 64
2019
Q2
$3.41M Buy
75,129
+11,049
+17% +$501K 0.52% 74
2019
Q1
$3.06M Buy
64,080
+9,850
+18% +$470K 0.48% 75
2018
Q4
$2.82M Sell
54,230
-34
-0.1% -$1.77K 0.51% 74
2018
Q3
$3.04M Hold
54,264
0.48% 74
2018
Q2
$3M Buy
54,264
+11,830
+28% +$655K 0.51% 74
2018
Q1
$2.68M Buy
42,434
+4,210
+11% +$266K 0.47% 78
2017
Q4
$2.34M Sell
38,224
-1,555
-4% -$95.3K 0.4% 85
2017
Q3
$2.54M Buy
+39,779
New +$2.54M 0.45% 84
2016
Q1
Sell
-4,687
Closed -$322K 113
2015
Q4
$322K Sell
4,687
-125
-3% -$8.59K 0.09% 103
2015
Q3
$285K Buy
+4,812
New +$285K 0.08% 108